Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02525913

Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to build a device that will consistently ablate (destroy or remove) cavitary breast tissue after a formal breast cancer resection in order to mimic the tissue that is now irradiated after breast cancer lumpectomy. The device would be easier to handle, perform the ablation in less time and by so ablating this margin would avoid the need in many for reoperation to obtain negative margins and based on preliminary data avoid the need for radiation. This would be especially important in poor and rural patients and would lead to decreased costs of treatment in patients with favorable breast cancer.

Conditions

Interventions

TypeNameDescription
DEVICERFA Applicator

Timeline

Start date
2015-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2015-08-18
Last updated
2015-10-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02525913. Inclusion in this directory is not an endorsement.

Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue (NCT02525913) · Clinical Trials Directory